3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
2
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
47
Carcinoma, Non-Small-Cell Lung
30
Pancreatic Neoplasms
24
Ovarian Neoplasms
23
Fallopian Tube Neoplasms
21
Triple Negative Breast Neoplasms
15
Breast Neoplasms, Male
14
Brenner Tumor
12
Melanoma
10
Carcinoma, Ovarian Epithelial
10
Unspecified Adult Solid Tumor, Protocol Specific
8
Lung Neoplasms
8
Uterine Cervical Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Adenocarcinoma of Lung
7
Urinary Bladder Neoplasms
6
Neoplasms
6
Adenocarcinoma, Bronchiolo-Alveolar
6
Neoplasm Metastasis
5
Stomach Neoplasms
4
Esophageal Neoplasms
4
Endometrial Neoplasms
4
Cholangiocarcinoma
4
Pleural Effusion, Malignant
3
Inflammatory Breast Neoplasms
3
Gallbladder Neoplasms
3
Carcinoma, Transitional Cell
3
Uveal Melanoma
2
Tongue Neoplasms
2
Thymoma
2
Interventions
Doxorubicin
80
Ifosfamide
54
Radiotherapy
43
Filgrastim
41
Gemcitabine
38
Cyclophosphamide
34
Etoposide
26
Vincristine
24
Cisplatin
24
Docetaxel
23
pazopanib
21
Trabectedin
19
Carboplatin
17
pembrolizumab
15
Peripheral Blood Stem Cell Transplantation
14
eribulin
12
Mesna
12
Melphalan
12
Sorafenib
11
Sirolimus
11
Irinotecan
11
Granulocyte Colony-Stimulating Factor
11
Bevacizumab
11
Topotecan
10
Paclitaxel
10
Imatinib Mesylate
10
Chemotherapy, Adjuvant
10
pegfilgrastim
9
Temozolomide
9
Surgical Procedures, Operative
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma
×
Taxes
×
Clear all
NCT03275818
2022-06-07
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Completed
69 enrolled